Depression Treatment with Duloxetine and Reduction of Inability to Work

Abstract EN

Data on inability to work from an observational study in patients treated with duloxetine for major depressive disorder in clinical practice in Germany were collected.

Ability to work was compared between baseline and up to 6 months after initiation of duloxetine.

All patients with a working status at baseline other than retired or retired early were included.

2,825 patients were analyzed, 54.8% were able to work at baseline increasing to 83.8% at 6 months.

Of those patients unable to work at baseline, 72.7% were able to work after 6 months.

A relevant reduction of inability to work was also found for patient subgroups with moderate to severe pain at baseline and those with and without MDD pretreatment.

As inability to work is one of the main cost drivers for depressive patients in Germany, the reduction of inability to work could potentially result in considerable cost savings for health insurance companies and society.